GLOBAL CORD BLOOD DL-0001

Loading quotes...

Forecast

Buy	2
Hold	3
Sell	0

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2018, GLOBAL CORD BLOOD DL-0001 has already paid €0.0696 in dividends. The last payout was in August 2018.

Financials

In the last year, GLOBAL CORD BLOOD DL-0001 had revenue of €177.11m and net profit of €71.38m

(EUR)	2022	YoY
Revenue	177.11m	17.36%
Gross profit	151m	18.31%
Net profit	71.38m	7.92%
EBITDA	89.58m	15.88%

Fundamentals

Metric	Value
Market capitalization	€362.94m
Number of shares	133.92m
52-week high/low	€3.26 - €0.54
Dividends	No
Beta	-0.04
P/E ratio	1.54
PEG ratio	-0.20
P/B ratio	0.16
P/S ratio	0.68

Company profile

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2021, it operated three cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Name	GLOBAL CORD BLOOD DL-0001
CEO	Ting Zheng
Headquarters	Central, Cayman Islands
Website	globalcordbloodcorp.com
Sector	Industrials
Industry	Professional Services
IPO	25/01/2007
Employees	1,202